Tak-Lun Que
-
Research
![Photo of [The Lancet] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial](https://fightcovid19.hku.hk/content/uploads/2020/02/cover-yuen-kwok-yung-1024x538-1-390x220.png)
[The Lancet] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
The Lancet, May 8 2020 Ivan Fan-Ngai Hung,Kwok-Cheung Lung,Eugene Yuk-Keung Tso,Raymond Liu,Tom Wai-Hin Chung,Man-Yee Chu,Yuk-Yung Ng,Jenny Lo,Jacky Chan,Anthony Raymond Tam,Hoi-Ping…
Read More »